Ethnicity and Chronic Kidney Disease in Africa

Adu, Dwomoa

doi:10.1016/b978-0-12-815876-0.00011-5

Cited by 3 publications

(5 citation statements)

References 117 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chronic kidney disease is a major public health problem with a global prevalence of 10%–13%; similar estimates of 13.9% have been reported in Sub‐Saharan Africa (Adu & Ojo, 2020 ; Hill et al, 2016 ; Stanifer et al, 2014 ). Chronic kidney disease patients eventually progress to end‐stage kidney disease (ESKD).…”

Section: Introductionsupporting

confidence: 53%

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Japiong,

Landy,

Fox

et al. 2023

Nursing Open

View full text Add to dashboard Cite

AimsThis scoping review examined the factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa.DesignScoping review.MethodsThe scoping review is conducted following the Joanna Briggs Institute methodology for scoping reviews and modelled by Preferred Reporting Items for Systematic Reviews and Meta‐analyses extension for scoping review.ResultsA descriptive content analysis of 30 included articles revealed three main findings affecting access and use of dialysis: Health system–related factors, health provider–related factors and patient factors.Patient or Public ContributionEquity in renal replacement therapy access and use will require concerted advocacy for good public policy, healthcare delivery, workforce capacity and education.

show abstract

Section: Introductionsupporting

confidence: 53%

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Japiong,

Landy,

Fox

et al. 2023

Nursing Open

View full text Add to dashboard Cite

show abstract

“…Glomerulonephritis and congenital abnormalities of the kidneys and urinary tract are the key sources of CKD in kids in Africa. The estimated prevalence of ESRD attributable to diabetes and hypertension in SSA is 239 per million people, although only 1.5% of patients receive renal replacement treatment 4 …”

Section: Backroundmentioning

confidence: 99%

“…The estimated prevalence of ESRD attributable to diabetes and hypertension in SSA is 239 per million people, although only 1.5% of patients receive renal replacement treatment. 4 …”

Section: Backroundmentioning

confidence: 99%

“…The estimated prevalence of ESRD attributable to diabetes and hypertension in SSA is 239 per million people, although only 1.5% of patients receive renal replacement treatment. 4 In Ethiopia, a study was done on the prevalence of CKD and its contributing factors. Thorough investigation and meta-analysis patients with CKD had a notably high prevalence of the chronic renal disease.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Joint modeling on serum creatinine and time to end stage of renal disease for chronic kidney disease patients under treatment at the University of Gondar Referral Hospital

Belay,

Melese,

Muhammed

2023

Health Science Reports

View full text Add to dashboard Cite

Background and AimsChronic kidney disease (CKD) is a major health problem worldwide. The general objective of this study is to identify the joint factors of serum creatinine (SCr) and time to end stage of renal disease (ESRD) for CKD patients under treatment at University of Gondar Referral Hospital (UOGRH).MethodsA retrospective cohort study was conducted. The collected information was secondary data type obtained from 311 CKD patient's medical charts in the UOGRH from September 2019 to January 2022 G.C. Joint modeling analysis contained a linear mixed model for SCr and the Cox‐PH model for time to ESRD of CKD patients under treatment was used.ResultFrom the total of 311 patients, 104 (33.4%) patients were developed the ESRD, while the other 207 (66.6%) were censored patients. In the longitudinal submodel, the variable sex, age, electrolyte, visit time, anemia, diabetes mellitus, chronic heart disease, hypertension, and hepatitis have a significant effect on the variable SCr. In survival process, anemia (HR = 2.53, p = < 0.001), diabetes mellitus (HR = 2.206, p = < 0.0047), chronic heart disease (HR = 2.83, p = < 0.0011), HIV (HR = 2.778, p = < 0.0045), hypertension (HR = 2.616, p = < 0.001), and hepatitis (HR = 4.4, p = < 0.0074) have a significant effect on the variable ESRD. On the basis of the result of the joint model, the variable anemia, diabetes mellitus, chronic heart disease, hypertension, and hepatitis were common significant factors.ConclusionThe majority of patients 207 (66.6%) of CKD patients were censored. On the basis of the smaller information criteria value and the significance association value, the joint model better fits the data. In the joint model, the variable anemia, diabetes mellitus, chronic heart disease, hypertension, and hepatitis were common factors of two responses, and also concluded that the rate of progression of longitudinal measure SCr decreased over time.

show abstract

“…Large egg deposits by Schistosoma mansoni in the human body result in Katayama fever, glomerular disease, hepatosplenic disease, and periportal fibrosis, which progress into fatal conditions such as portal hypertension and ascites [ 11 , 12 ]. Praziquantel (Biltricide®) is the most recognized drug to treat Schistosomiasis at the moment [ 13 , 14 ], while Oxamniquine has been allowed to be used, though it is specific to some species [ 15 ].…”

Section: Introductionmentioning

confidence: 99%

Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis

Anyubaga,

Shallangwa,

Uzairu

et al. 2024

Heliyon

View full text Add to dashboard Cite

Ethnicity and Chronic Kidney Disease in Africa

Cited by 3 publications

References 117 publications

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Factors affecting access to dialysis for patients with end‐stage kidney disease in Sub‐Saharan Africa: A scoping review

Joint modeling on serum creatinine and time to end stage of renal disease for chronic kidney disease patients under treatment at the University of Gondar Referral Hospital

Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis

Contact Info

Product

Resources

About